The Manufacturers Life Insurance Company Sells 714 Shares of Doximity, Inc. (NASDAQ:DOCS)

The Manufacturers Life Insurance Company cut its holdings in Doximity, Inc. (NASDAQ:DOCS) by 0.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 100,905 shares of the company’s stock after selling 714 shares during the period. The Manufacturers Life Insurance Company’s holdings in Doximity were worth $4,396,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in DOCS. First Horizon Advisors Inc. increased its stake in Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after acquiring an additional 384 shares during the last quarter. GAMMA Investing LLC lifted its position in Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the last quarter. Van ECK Associates Corp boosted its stake in Doximity by 19.7% during the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after buying an additional 427 shares during the period. Cornercap Investment Counsel Inc. increased its position in Doximity by 3.2% during the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock valued at $479,000 after acquiring an additional 537 shares during the last quarter. Finally, Farther Finance Advisors LLC raised its stake in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after acquiring an additional 603 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Stock Up 0.4 %

Doximity stock opened at $55.54 on Friday. The firm has a market cap of $10.37 billion, a P/E ratio of 63.59, a P/E/G ratio of 4.34 and a beta of 1.40. The business has a fifty day moving average of $46.86 and a two-hundred day moving average of $36.82. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75.

Analysts Set New Price Targets

A number of research firms recently weighed in on DOCS. KeyCorp raised shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a research report on Friday, November 8th. Canaccord Genuity Group downgraded Doximity from a “buy” rating to a “hold” rating and increased their price target for the stock from $40.00 to $60.00 in a report on Wednesday, November 13th. Wells Fargo & Company upgraded Doximity from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $19.00 to $41.00 in a report on Friday, November 8th. Morgan Stanley upgraded Doximity from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, The Goldman Sachs Group initiated coverage on shares of Doximity in a research note on Friday, November 15th. They set a “neutral” rating and a $58.00 target price for the company. Twelve analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $52.44.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.